✦ LIBER ✦

Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib

✍ Scribed by Luster, T. A.; Carrell, J. A.; McCormick, K.; Sun, D.; Humphreys, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of selective fully human agonis

✍ Georgios V. Georgakis; Yang Li; Robin Humphreys; Michael Andreeff; Susan O'Brien 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

Phase II Trial of Mapatumumab, a Fully H

✍ von Pawel, Joachim; Harvey, Jimmie H.; Spigel, David R.; Dediu, Mircea; Reck, Ma 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 569 KB

Phase II trial of mapatumumab, a fully h

✍ Trarbach, T; Moehler, M; Heinemann, V; Köhne, C-H; Przyborek, M; Schulz, C; Snel 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 318 KB